Recent progress in clinical and laboratory investigations has shown that Human Umbilical Cord Blood (UCB) contains cells capable of sustained hematopoietic engraftment, and therefore UCB has vast potential as a source of hematopoietic stem cells for allogeneic and autologous bone marrow transplantation. UCB is particularly attractive because of the possibility that its use might decrease the incidence and severity of graft versus host disease, and thereby decrease overall post-transplant complications. UCB offers major theoretical benefits as a treatment for hemoglobinopathies, where the high disease incidence in non-Caucasian patients makes matched unrelated donor bone marrow searches problematic at present. Several issues need to be addressed however, before UCB can be routinely used as a transfusion product for stern cell support, including increasing the number of transplantable stem cells available from a given volume of UCB, and developing a UCB bank that maximizes the chances of banked UCB units to be used for clinical transplants. It is the intent of this project to attack these issues, with the goal of transforming UCB from an exotic research field to a routine blood bank transfusion therapy that will be of decisive benefit to common, serious diseases such as sickle cell anemia. In particular, we plan to develop a facility that will be tailored for correction of homozygous Sickle Cell Anemia by human umbilical cord blood cell transplantation. The program will both target our loco-regional population, heavily represented by African-Americans, and will serve as a national resource as well. To achieve this goal, we propose two Specific Aims: 1) To develop a HUCB bank targeted at the African-American population, emphasizing application towards correction of Sickle Cell Disease, and 2) To explore and develop techniques of HUCB stem cell expansion. Achieving these two goals should make major studies towards enabling the widespread cure of SS disease through HUCB transplantation.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Specialized Center (P50)
Project #
5P50HL054516-04
Application #
6110497
Study Section
Project Start
1999-01-01
Project End
1999-12-31
Budget Start
1998-10-01
Budget End
1999-09-30
Support Year
4
Fiscal Year
1999
Total Cost
Indirect Cost
Name
University of Pennsylvania
Department
Type
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Siegel, Don L (2008) Translational applications of antibody phage display. Immunol Res 42:118-31
Siegel, Don L (2007) Phage display-based molecular methods in immunohematology. Transfusion 47:89S-94S
Xie, Kefang; Song, Shuh Chyung; Spitalnik, Steven L et al. (2005) Crystallographic analysis of the NNA7 Fab and proposal for the mode of human blood-group recognition. Acta Crystallogr D Biol Crystallogr 61:1386-94
Siegel, Don L (2005) Developing phage display tools for use in transfusion medicine. Transfusion 45:100S-108S
Song, Shuh Chyung; Xie, Kefang; Czerwinski, Marcin et al. (2004) Purification, crystallization and X-ray diffraction analysis of a recombinant Fab that recognizes a human blood-group antigen. Acta Crystallogr D Biol Crystallogr 60:788-91
Young, Donald S; Sachais, Bruce S; Jefferies, Leigh C (2002) Effect of disease complications on hospital costs. Clin Chem 48:140-9
Honczarenko, Marek; Le, Yi; Glodek, Aleksandra M et al. (2002) CCR5-binding chemokines modulate CXCL12 (SDF-1)-induced responses of progenitor B cells in human bone marrow through heterologous desensitization of the CXCR4 chemokine receptor. Blood 100:2321-9
Siegel, D L (2002) Recombinant monoclonal antibody technology. Transfus Clin Biol 9:15-22
Czerwinski, Marcin; Krop-Watorek, Anna; Lisowska, Elwira et al. (2002) Construction of dimeric F(ab) useful in blood group serology. Transfusion 42:257-64
Jefferies, L C; Sachais, B S; Young, D S (2001) Blood transfusion costs by diagnosis-related groups in 60 university hospitals in 1995. Transfusion 41:522-9

Showing the most recent 10 out of 26 publications